31.10.2012
- British academic researchers have secured 7 million pounds ($11 million) of funding from the country's Medical Research Council (MRC) to investigate a range of potential new drugs...
29.10.2012
- Struggling British drugmaker AstraZeneca is giving its new chief executive Pascal Soriot 4 million pounds ($6.44 million) compensation for loss of long-term incentives from his...
25.10.2012
- AstraZeneca's sales slumped 19% in the third quarter, underscoring the scale of the challenge confronting the drugmaker's new chief executive, Pascal Soriot. Faced with patent...
01.10.2012
- AstraZeneca has suspended its share buyback program, giving new chief executive Pascal Soriot more leeway to devise a strategy to return the British drugmaker to growth. The...
25.09.2012
- A Pill a Day - Unlike chemicals, the pharmaceuticals sector does not have cycles. Even in a sluggish economy, sick people will still need medicine. But the widening European debt...
25.09.2012
- Market Transition - When we think about the patent cliff, an image along the lines of a massive waterfall, with companies' revenues in free fall comes to mind. What we usually...
24.09.2012
- French drugmaker Sanofi will reveal on Tuesday how it plans to shake up its French research operations in a cost-cutting drive which unions predict could mean up to 2,500 layoffs...
28.08.2012
- AstraZeneca has poached Pascal Soriot from rival Roche Holding to be its new chief executive, hoping his track record in drug innovation and dealmaking can revive a company...
